ArticleCancer cell international2022

Development and validation of a nomogram for evaluating the prognosis of immunotherapy plus antiangiogenic therapy in non-small cell lung cancer.

Hao Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.